| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |